null
null
position
long
Gavin Baker, Atreides Management
Thesis
The investor is considering Gerresheimer AG due to its strong position in the syringe market and the expected growth from GLP-1 contracts, which are projected to significantly increase revenue and margins over the next few years. The management's focus on improving cash flow and return metrics adds to the attractiveness of the investment.
Did it work?
inconclusive
confidence: low
Without specific price performance data or a defined time frame since the pitch, it's difficult to assess whether the thesis has played out. The expected growth from GLP-1 contracts and management's focus on cash flow improvements are positive indicators, but without concrete results or timelines, the outcome remains uncertain.
Raw excerpt
No raw excerpt stored.